Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China

International Journal of Gynecological Cancer

Volumn 21, Issue 3, 2011, Pages 551-558

  Sun, Zhengrong ^a   Ren, Gaowei ^a   Cui, Xin ^a   Zhou, Weiqiang ^a   Liu, Chao ^a   Ruan, Qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

E6 E7 L1 genes; Genetic diversity; HPV 16

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CANCER GRADING; CANCER INVASION; CHINA; FEMALE; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VIRUS GENE; ADOLESCENT; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS;

CAPSID PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN E7; REPRESSOR PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; CAPSID PROTEINS; CHINA; DNA, VIRAL; FEMALE; GENETIC VARIATION; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; REPRESSOR PROTEINS; UTERINE CERVICAL DISEASES; YOUNG ADULT;

EID: 80051623166     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182112023     Document Type: Article

References (30)

1. Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265. (Pubitemid 34293391)
2. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129-1136. (Pubitemid 120035062)
3. Münger K, Werness BA, Dyson N, et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989;8:4099-4105. (Pubitemid 20066852)
4. Garbuglia AR, Carletti F, Minosse C, et al. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. New Microbiol. 2007;30:377-382. (Pubitemid 350183836)
5. Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol. 1993;67:6929-6936. (Pubitemid 23343814)
6. Alvarez-Salas LM, DiPaolo JA. Molecular approaches to cervical cancer therapy. Curr Drug Discov Technol. 2007;4:208-219. (Pubitemid 350171822)
7. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
8. Liu X, Zhang S, Ruan Q, et al. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer. 2010;20:147-153.
9. Yamada T, Wheeler CM, Halpern AL, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69:7743-7753.
10. Seedorf K, Krämmer G, Dürst M, et al. Human papillomavirus type 16 DNA sequence. Virology. 1985;145:181-185. (Pubitemid 15234421)
11. Andersson S, Alemi M, Rylander E, et al. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer. 2000;83:307-310. (Pubitemid 30453568)
12. Matsumoto K, Yoshikawa H, Nakagawa S, et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett. 2000;156:159-165. (Pubitemid 30394673)
13. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000;81:2959-2968. (Pubitemid 32000643)
14. Tornesello ML, Duraturo ML, Salatiello I, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004;74:117-126. (Pubitemid 38988868)
15. Bontkes HJ, van Duin M, de Gruijl TD, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer. 1998;78:166-171. (Pubitemid 28443172)
16. Ellis JR, Keating PJ, Baird J, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995;1:464-470.
17. Phelps WC, Munger K, Yee CL, et al. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol. 1992;66:2418-2427.
18. Ding T, Wang X, Ye F, et al. Distribution of human papillomavirus 16 E6/e7 variants in cervical cancer and intraepithelial neoplasia in Chinese women. Int J Gynecol Cancer. 2010;20:1391-1398.
19. Pillai MR, Hariharan R, Babu JM, et al. Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int J Cancer. 2009;125:91-103.
20. Pande S, Jain N, Prusty BK, et al. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in North India. J Clin Microbiol. 2008;46:1060-1066. (Pubitemid 351380001)
21. Song YS, Kee SH, Kim JW, et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol. 1997;66:275-281. (Pubitemid 27335417)
22. De Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 16 E6, E7 and L1 variants in cervical cancer in Indonesia, Surinam, The Netherlands. Gynecol Oncol. 2004;94:488-494. (Pubitemid 39024558)
23. Smahel M, Tejklova P, Smahelova J, et al. Mutation in the immunodominant epitope of HPV 16 E7 oncoprotein as a mechanism of tumor escape. Cancer Immunol Immunother. 2008;57:823-831. (Pubitemid 351660126)
24. Hildesheim A, Schiffman M, Bromley C, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93:315-318. (Pubitemid 32219819)
25. Muller M, Zhou J, Reed TD, et al. Chimeric papillomavirus-like particles. Virology. 1997;234:93-111. (Pubitemid 27316610)
26. Chen XS, Garcea RL, Goldberg I, et al. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell. 2000;5:557-567.
27. Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007;120:1763-1768. (Pubitemid 46399363)
28. Yang R, Wheeler CM, Chen X, et al. Papillomavirus capsid mutation to escape dendritic cell dependent innate immunity in cervical cancer. J Virol. 2005;79:6741-6750. (Pubitemid 40677305)
29. White WI, Wilson SD, Palmer-Hill FJ, et al. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol. 1999;73:4882-4889. (Pubitemid 29246748)
30. Cento V, Ciccozzi M, Ronga L, et al. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. J Med Virol. 2009;81:1627-1634.